methylene blue has been researched along with Viral Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chu, LF; Chu, MC; Chu, S; Clark, T; Conly, JM; Cui, Y; Dams, L; Davies, JM; De Jaeger, S; Evans, D; Faris, P; Gallagher, T; Harcourt, BH; Haubruge, E; Heyne, B; Homdayjanakul, K; Hope, K; Jolois, O; Kabra, KB; Kilinc-Balci, FS; Lamb, MM; Laperre, J; Lemyre, JL; Lendvay, TS; Liao, L; Lin, YC; Lin, YL; Ludwig-Begall, LF; Macia, N; Mackie, CJ; Malott, R; Mayo, M; Molloy-Simard, V; Mores, CN; Nauwynck, H; Page, K; Parker, R; Patel, AN; Price, A; Reader, S; Sahni, J; Scholte, FEM; Simmons, SM; Smit, SJ; Thiry, E; Timm, E; Tritsch, SR; Wagner, T; Wielick, C; Willaert, JF; Zhao, M | 1 |
| Bardiaux, L; Bartelmaos, T; Chabanel, A; Courtois, F; Denninger, MH; Gillon, MC; Giraudeau, B; Gomola, A; Léger, J; Naegelen, C; Ozier, Y; Rouget, C; Tardivel, R; Villalon, L | 1 |
| Pereira, A | 1 |
| Shastina, GV; Tsinzerling, AV | 1 |
| Vyas, GN | 1 |
| Dodd, RY | 1 |
| Mathias, JM; Pamphilon, DH; Payrat, JM; Rider, JR; Winter, MA | 1 |
| Mohr, H | 1 |
| Hornsey, VS; Krailadsiri, P; MacDonald, S; Prowse, CV; Seghatchian, J; Williamson, LM | 1 |
| Aznar, JA; Bonanad, S; Cid, AR; De Miguel, A; Hurtado, C; Montoro, JM; Soler, MA | 1 |
| Wagner, SJ | 1 |
| Herzberg, K; May, G | 1 |
4 review(s) available for methylene blue and Viral Diseases
| Article | Year |
|---|---|
[Viral safety measures of plasma for transfusion and applicability in Spain].
Topics: Blood Coagulation Factors; Blood Donors; Blood Transfusion; Clinical Trials, Phase III as Topic; Consumer Product Safety; Forecasting; Humans; Methylene Blue; Plasma; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Safety; Spain; Transfusion Reaction; Ultraviolet Rays; Viremia; Virus Diseases; Viruses | 2007 |
Viral inactivation in platelet concentrates.
Topics: Blood Platelets; Ficusin; Humans; Methylene Blue; Photosensitizing Agents; Platelet Transfusion; Risk Factors; Ultraviolet Rays; Virus Diseases | 1994 |
Virus inactivation of fresh plasma.
Topics: Biological Products; Blood Transfusion; Detergents; Drug Contamination; Humans; Light; Methylene Blue; Plasma; Safety; Solvents; Sterilization; Transfusion Reaction; Virus Diseases; Viruses | 1998 |
Virus inactivation in blood components by photoactive phenothiazine dyes.
Topics: Blood; Blood Platelets; Coloring Agents; DNA Damage; Energy Transfer; Erythrocytes; Humans; Methylene Blue; Phenothiazines; Photochemistry; Photons; Photosensitizing Agents; Plasma; Reactive Oxygen Species; Safety; Singlet Oxygen; Transfusion Reaction; Virus Diseases; Viruses | 2002 |
1 trial(s) available for methylene blue and Viral Diseases
| Article | Year |
|---|---|
Plasma transfusion in liver transplantation: a randomized, double-blind, multicenter clinical comparison of three virally secured plasmas.
Topics: Blood Loss, Surgical; Detergents; Double-Blind Method; Enzyme Inhibitors; Female; Hemostasis; Humans; Linear Models; Liver Diseases; Liver Transplantation; Male; Methylene Blue; Middle Aged; Plasma; Postoperative Complications; Quarantine; Risk Factors; Solvents; Treatment Outcome; Virus Diseases | 2013 |
7 other study(ies) available for methylene blue and Viral Diseases
| Article | Year |
|---|---|
Addressing personal protective equipment (PPE) decontamination: Methylene blue and light inactivates severe acute respiratory coronavirus virus 2 (SARS-CoV-2) on N95 respirators and medical masks with maintenance of integrity and fit.
Topics: COVID-19; Decontamination; Equipment Reuse; Humans; Masks; Methylene Blue; N95 Respirators; Personal Protective Equipment; SARS-CoV-2; Virus Diseases | 2022 |
[On the detection in sections of fuchsinophilic inclusions in several viral infections].
Topics: Cytoplasmic Granules; Humans; Methylene Blue; Rosaniline Dyes; Virus Diseases | 1966 |
Inactivation and removal of blood-borne viruses.
Topics: Anthracenes; Antiviral Agents; Blood; Blood Transfusion; Furocoumarins; Humans; Immunoglobulin G; Indoles; Isoindoles; Light; Methylene Blue; Perylene; Virus Diseases; Viruses | 1995 |
Leucocytes can be eliminated from plasma by filtration prior to viral inactivation with methylene blue.
Topics: Antiviral Agents; Filtration; Freezing; Humans; Leukocytes; Lymphocyte Depletion; Methylene Blue; Plasma; Virus Diseases; Viruses | 1998 |
Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma.
Topics: Antigens; Cold Temperature; Enzyme Inhibitors; Factor VIII; Fibrinogen; Humans; Methylene Blue; Photochemotherapy; Virus Diseases; Viruses; von Willebrand Factor | 2000 |
Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
Topics: Antiviral Agents; Blood Coagulation Factors; Blood Coagulation Tests; Blood Preservation; Blood Transfusion; Cryopreservation; Humans; Infection Control; Methylene Blue; Photochemistry; Plasma; Safety; Virus Diseases; Viruses | 2000 |
[Comparison of an agent of a communicable disease of monkeys with a vesicular stomatitis virus. II].
Topics: Amnion; Animals; Culture Techniques; Haplorhini; Humans; Methylene Blue; Microscopy, Electron; Monkey Diseases; Species Specificity; Staining and Labeling; Ultracentrifugation; Vesicular stomatitis Indiana virus; Virus Diseases; Virus Replication; Viruses, Unclassified | 1969 |